Posted Jan. 6, 2017
Prescribing buprenorphine-naloxone (Suboxone) occurs in the context of addiction treatment, a complex area of practice that is emerging internationally for nurse practitioners.
The CRNBC Board on Dec. 2
approved the expansion of NP scope to include continuation prescribing of buprenorphine-naloxone. This change is now in effect.
The new standards, limits and conditions (including additional education requirements),
D. Opioid Agonist Therapy | Continuation Prescribing of Buprenorphine-Naloxone, have been incorporated into the
NP Scope document (pg 33).
The new standard should be used in conjunction with the prescribing standard limits and conditions.
Focus group: Continuation of prescribing methadone by NPs